By Stephen Ditmore Acute COVID-19 Clinical Trials There are four clinical trials of Low Dose Naltrexone (LDN) as an acute COVID-19 therapeutic in the United States, two of which are currently recruiting. Statera BioPharma (formerly Cytocom), which calls its...
Low Dose Naltrexone Emerges as an Investigational Long COVID Therapeutic
read more